When a patient is experiencing symptoms of preterm labour, you need to determine if her risk of preterm birth is real or perhaps quite low.1
Fetal fibronectin (fFN) testing detects concentration levels of the fFN protein to reliably indicate whether a woman is likely to give birth prematurely.2
fFN acts as an adhesive glycoprotein at the maternal-fetal interface that bonds maternal membranes to fetal membranes.
It is a biomarker for preterm delivery and is highly associated with the risk of preterm delivery when present in cervicovaginal secretions.
fFN testing is the only named biomarker test recommended by the NICE clinical guidelines for the risk assessment of preterm labour & birth.3
Quantitative fFN testing detects the concentration levels of fFN that are present, giving you the data you need to determine a woman’s risk of preterm delivery.2
This link will take you to the information intended for healthcare professionals outside of the United States. Because these pages concern the international distribution activities of the QuikCheckTM fFN Test, which are not necessarily governed by US law, contents of the international pages may contain information that does not pertain to US users, including certain products that may not be cleared or approved by US Food & Drug Administration for promotion or sale in the United States. Click “Continue” to proceed, or click “Cancel” to remain in the US site.
Caution: The QuikCheck fFNTest is not sold or offered for sale in the United States or Canada.
Hologic, Inc. does not review nor control the content on non-Hologic websites. This link does not constitute an endorsement by Hologic of the content of the site you are about to visit. Hologic privacy procedures do not apply to the owners of a non-Hologic website.